Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by BROOKFIELD Corp ON

BROOKFIELD Corp ON lowered its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 11.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,278,619 shares of the real estate investment trust's stock after selling 165,318 shares during the period. BROOKFIELD Corp ON owned 0.18% of Healthpeak Properties worth $25,918,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Principal Financial Group Inc. lifted its position in Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust's stock worth $367,575,000 after acquiring an additional 17,314,572 shares during the period. Norges Bank acquired a new position in shares of Healthpeak Properties in the fourth quarter valued at about $166,804,000. Long Pond Capital LP purchased a new position in shares of Healthpeak Properties in the fourth quarter worth about $86,885,000. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust's stock worth $493,115,000 after purchasing an additional 4,056,931 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of Healthpeak Properties by 32.6% during the fourth quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after purchasing an additional 2,590,530 shares during the period. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Price Performance

Healthpeak Properties stock traded up $0.11 during midday trading on Friday, reaching $17.50. The company had a trading volume of 4,245,778 shares, compared to its average volume of 4,950,215. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a 12-month low of $17.21 and a 12-month high of $23.26. The company has a market capitalization of $12.16 billion, a P/E ratio of 50.00, a P/E/G ratio of 2.17 and a beta of 1.05. The firm's fifty day simple moving average is $19.14 and its 200-day simple moving average is $20.29.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The business had revenue of $702.89 million for the quarter, compared to the consensus estimate of $690.76 million. During the same quarter last year, the business posted $0.45 earnings per share. The business's quarterly revenue was up 15.9% compared to the same quarter last year. As a group, equities analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a dividend, which was paid on Wednesday, April 30th. Stockholders of record on Friday, April 18th were issued a dividend of $0.1017 per share. This represents a dividend yield of 6.5%. The ex-dividend date was Thursday, April 17th. Healthpeak Properties's payout ratio is 305.00%.

Analyst Upgrades and Downgrades

DOC has been the subject of a number of recent research reports. Wedbush reduced their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. StockNews.com cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a report on Thursday, May 1st. Scotiabank cut their price target on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research report on Friday, February 28th. Robert W. Baird decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Finally, Evercore ISI reduced their price target on Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and an average target price of $23.42.

Insider Activity

In related news, CEO Scott M. Brinker bought 11,337 shares of the stock in a transaction dated Monday, April 28th. The shares were acquired at an average cost of $17.68 per share, for a total transaction of $200,438.16. Following the acquisition, the chief executive officer now directly owns 201,863 shares in the company, valued at approximately $3,568,937.84. This trade represents a 5.95 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John T. Thomas purchased 4,200 shares of the business's stock in a transaction that occurred on Monday, April 28th. The stock was bought at an average cost of $17.84 per share, with a total value of $74,928.00. Following the acquisition, the director now owns 813,566 shares of the company's stock, valued at approximately $14,514,017.44. The trade was a 0.52 % increase in their position. The disclosure for this purchase can be found here. Company insiders own 0.23% of the company's stock.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.